Chilton Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Chilton Capital Management's LLY Position: Q1 2026 in Review
Chilton Capital Management increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $9.23M and bringing the position to 76,231 shares worth $70.1M. The position accounts for 2.44% of the portfolio, ranked #9.
Chilton Capital Management first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $72.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Chilton Capital Management held 76,231 shares of Eli Lilly worth $70.1M as of Q1 2026.
- Chilton Capital Management bought 9,101 Eli Lilly shares in Q1 2026, an estimated $9.23M.
- Eli Lilly made up 2.44% of Chilton Capital Management's portfolio in Q1 2026, its #9 holding.
- Chilton Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- Chilton Capital Management's Eli Lilly position peaked at $72.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.